Getinge (OTCMKTS:GNGBY) Stock Passes Above 50-Day Moving Average – Should You Sell?

Getinge (OTCMKTS:GNGBYGet Free Report)’s share price crossed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $20.41 and traded as high as $20.83. Getinge shares last traded at $20.80, with a volume of 1,128 shares traded.

Wall Street Analysts Forecast Growth

Separately, Zacks Research raised shares of Getinge to a “hold” rating in a research report on Thursday, April 23rd. One equities research analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy”.

Check Out Our Latest Stock Analysis on GNGBY

Getinge Stock Performance

The company has a current ratio of 1.32, a quick ratio of 0.86 and a debt-to-equity ratio of 0.27. The stock has a fifty day moving average price of $20.41 and a 200-day moving average price of $21.46. The firm has a market capitalization of $5.67 billion, a price-to-earnings ratio of 22.61 and a beta of 0.96.

Getinge Company Profile

(Get Free Report)

Getinge AB is a global medical technology company that develops, manufactures and markets products and systems for hospitals and life sciences institutions. The company’s offerings focus on critical care, surgical workflows and infection control, aiming to improve clinical outcomes and operational efficiency. Getinge’s solutions support a range of applications from intensive care and cardiovascular treatments to sterile reprocessing of surgical instruments.

The company’s product portfolio includes sterilization and disinfection equipment, surgical tables and lights, ventilation systems, heart-lung machines and extracorporeal membrane oxygenation (ECMO) devices.

Featured Stories

Receive News & Ratings for Getinge Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Getinge and related companies with MarketBeat.com's FREE daily email newsletter.